GEN

Affymetrix: More Than Microarrays

Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...
Business Wire

Affymetrix and Ariosa Diagnostics Announce Signing of Multi-Year Supply Agreement in Support of Ariosa’s Non-Invasive Prenatal Test

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...
Business Wire

Family Tree DNA Launches Family Finder DNA Test Using Affymetrix Microarray Technology

HOUSTON & SANTA CLARA, Calif.--(BUSINESS WIRE)--Family Tree DNA, the first and largest genealogical DNA testing company, today announced the launch of the Family Finder DNA test for connecting family ...
technologynetworks

Affymetrix Participates in Study to Advance MicroArray Technology Towards Widespread Clinical Use

Affymetrix Inc. has announced the publication of the MicroArray Quality Control (MAQC) study, a collaborative effort led by the FDA that included 137 scientists from private and public sector ...
The Scientist

Affymetrix Showcases Third-Party Microarray Analysis Software

Like it or not, biologists have to deal increasingly in informatics as their experiments generate ever larger and more complex data sets. Few laboratories have the resources to develop their own ...
Science Daily

Getting More From Whole-transcript Microarrays

The widely used Affymetrix Whole-Transcript Gene 1.0 ST (sense target) microarray platform, normally used to assay gene expression, can also be utilized to interrogate exon-specific splicing. A new ...
FiercePharma

Affymetrix Launches Advanced RNA Amplification Technology for Whole-Genome Expression Analysis of FFPE Samples

Mindy Lee-Olsen, 408-731-5523 (Media)Vice President, Marketing ServicesorDoug Farrell, 408-731-5285 (Investors)Vice President, Investor Relations (NASDAQ:AFFX) announced today the availability of ...
FierceBiotech

Affymetrix and BGI Enter Strategic Collaboration to Co-Develop and Commercialize Genomic Microarrays for the Agricultural

Collaboration to expand research and molecular breeding tools for enhancing plant, crop, and livestock production outcomes SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NASDAQ:AFFX), ...
GEN

Ingenuity, Affymetrix Pair Products to Curb Microarray Bottlenecks

Ingenuity Systems and Affymetrix will be co-promoting Ingenuity® iReport™ with Affymetrix’ expression microarray products to help eliminate a bottleneck for researchers working with human, mouse, and ...
FierceBiotech

Affymetrix Names GenoSplice as Its Preferred Data Analysis Service Provider Increasing Accessibility for Bioinformatics in Genomic Research

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) announced a co-marketing agreement today naming GenoSplice, Inc. as its preferred data analysis service provider for the new ...
EurekAlert!

Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible™ status

Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...
Nature

The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance

Discover the latest articles and news in related subjects. Specifically, we report the results of a comparative analysis of gene expression responses profiled by Affymetrix microarray and Illumina RNA ...